Digital Biomarkers & Endpoints — Powered by Real-World Data.

From physiology to function, Delve transforms raw wearable signals into validated, regulator-aligned digital measures you can trust in clinical development.

Explore the Endpoint Library

From Raw Signals to Regulator-Ready Evidence

Wearable data is noisy, inconsistent, and device-dependent. Digital biomarkers solve this by applying validated algorithms, statistical models, and context-aware transformations that turn continuous sensor data into meaningful, clinical-grade measurements.

Delve enables sponsors to rapidly deploy, validate, and scale digital biomarkers aligned with FDA, EMA, and PMDA digital health technology frameworks.

Digital biomarker overview

Our 3-Phase Digital Endpoint Validation Framework

1. Correlation & Feasibility

Compare sensor-derived signals against gold-standard clinical tools to confirm feasibility.

2. Algorithm Training & Calibration

Generate reproducible, device-agnostic algorithms with consistent sampling and signal quality.

3. Verification & Submission Readiness

Measurement accuracy, variance, reproducibility, and context-of-use verification for FDA/EMA review.

Digital Biomarker Library

Delve supports a broad and continuously expanding catalog of digital biomarkers. Each is validated for physiological accuracy, sampling reliability, and clinical interpretability.

Cardiovascular

  • Heart Rate
  • HR Variability (RMSSD, SDNN)
  • Pulse Morphology
  • AFib Risk Indicators

Respiratory

  • Respiratory Rate
  • Nocturnal RR Trends
  • Breath Variability
  • Activity-adjusted Respiratory Burden

Activity & Function

  • Gait Speed
  • Step Count Accuracy
  • 6MWT Digital Equivalent
  • Functional Mobility Signatures

Sleep & Circadian

  • Sleep Stages
  • Fragmentation Index
  • Circadian Rhythm Stability
  • Sleep Efficiency

Subjective + Objective = True Digital Endpoints

The future of endpoints is hybrid. Delve fuses wearable signals with ePRO triggers, symptom diaries, and clinician assessments to produce composite endpoints with richer explanatory power.

This is how Delve reveals the story behind every datapoint — the human experience inside the physiology.

Wearables + eCOA fusion

Digital Biomarkers in Action

Cardio-Oncology Study

Real-time HRV + symptom correlation predicted early toxicity signals.

Respiratory Trial

Nocturnal respiratory patterns improved early exacerbation detection.

Mobility Study

Gait speed and 6MWT digital equivalents aligned with clinician assessments.

Explore Delve’s Digital Biomarker Portfolio

See how validated digital endpoints can accelerate your next study.

Book a Demo